Daily non-political popular news in brief.
1st successful treatment for chronic TBI
10-11-2007 · EurekAlert!A research team led by Dr. Paul Harch, Assistant Professor of Clinical Medicine at Louisiana State University Health Sciences Center New Orleans and Director of the LSU Hyperbaric Medicine Fellowship Program, has published findings that show hyperbaric oxygen therapy improved spatial learning and memory in a model of chronic traumatic brain injury.
Read more »
Keywords: 1st, successful, treatment, chronic, tbi
« Previous | Next »
Similar news on "1st successful treatment for chronic TBI":
- New biologic treatment for tennis elbow may replace surgery for chronic sufferers
10-23-2006 · EurekAlert!
"Tennis elbow" isn't restricted to tennis players; it's a common, chronic problem for people whose activities require strong gripping or repetitive wrist motions. A novel biologic treatment of injecting the patient's own platelets into the affected tendon proves successful and gives patients another treatment option before undergoing surgery. The procedure has wide application for healing of other medical conditions, say researchers from Stanford University.
Similar news · Read more »
- Promising treatment for post traumatic stress disorder sleep disturbances
04-17-2007 · EurekAlert!
For sufferers of post traumatic stress disorder, sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. Previously, there has been little success in treating these sleep disorders with psychopharmacologic approaches. In a study in the April 15 issue of Biological Psychiatry, researchers have found that an inexpensive, widely available drug was successful in reducing symptoms in chronic PTSD patients.
Similar news · Read more »
- Promising treatment for post-traumatic stress disorder sleep disturbances
04-17-2007 · EurekAlert!
For sufferers of post-traumatic stress disorder, sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. Previously, there has been little success in treating these sleep disorders with psychopharmacologic approaches. In a study in the April 15 issue of Biological Psychiatry, researchers have found that an inexpensive, widely available drug was successful in reducing symptoms in chronic PTSD patients.
Similar news · Read more »
- Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today
01-31-2008 · EurekAlert!
Many patients with a chronic disease or cancer have to contend with anemia. At present, the hormone EPO is administered to a large number of these patients to alleviate the anemia. But unfortunately, treatment with EPO is not always effective. VIB scientists have been researching the role of the Gas6 protein. This substance has proven successful in the treatment of mice with anemia. In addition, Gas6 contributes to a reinforcement of EPO's effect.
Similar news · Read more »
- Interferon-treated hepatitis C patients likely to experience retinopathy
01-03-2007 · EurekAlert!
Persons with chronic hepatitis C being treated with Interferon (IFN) are at risk of developing retinopathy as early as two weeks into treatment according to the results of a new study published in the January 2007 issue of Investigative Ophthalmology & Visual Science (IOVS).
Similar news · Read more »
- Enzyme critical for early growth of abdominal aortic aneurysms
02-13-2007 · EurekAlert!
Surgery is the only treatment for an abdominal aortic aneurysm, a weak spot in the body's main artery that dilates dangerously over time. If the vessel ruptures suddenly before surgery to repair it, a quick death is virtually certain. Now, scientists say they have identified a key enzyme that triggers chronic inflammation in the aorta and promotes the growth of aneurysms. Their finding raises hopes for developing a drug that could prevent small aneurysms from enlarging to the point where surgery is necessary.
Similar news · Read more »
- Growth-factor antibody may treat chronic lung disease affecting premature infants
04-02-2007 · EurekAlert!
Researchers from Massachusetts General Hospital, in collaboration with scientists from the Genzyme Corporation, have identified a potential treatment for a chronic lung disease affecting premature infants. The scientists find that the activity of transforming growth factor-beta is elevated in the lungs of an animal model of bronchopulmonary dysplasia and that treatment with an antibody to TGF-beta decreased the growth factor’s activity and improved lung development.
Similar news · Read more »
- Vaccine prevents prion disease in mice
05-03-2007 · EurekAlert!
An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease, according to research that will be presented at the American Academy of Neurology's 59th annual Meeting in Boston, April 28-May 5, 2007. Prion diseases, which include scrapie, mad cow disease and chronic wasting disease, are fatal, and there is no treatment or cure.
Similar news · Read more »
- Drug has ability to cure type of leukemia
10-02-2007 · EurekAlert!
In people with chronic myeloid leukemia, the drug imatinib has been shown to drive cancer into remission, but the disease often returns when treatment is stopped. New research by UC Irvine scientists indicates that imatinib could cure CML under certain circumstances if it is taken over a long enough period of time.
Similar news · Read more »
- Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
Similar news · Read more »
